Difference between revisions of "Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5 (Q9536)"
Jump to navigation
Jump to search
(Created claim: Fifth Author string (P153): Yu Dae-Yeul, #quickstatements; #temporary_batch_1590155508986) |
(Created claim: Sixth Author string (P154): Jeong Dong Kee, #quickstatements; #temporary_batch_1590155721863) |
||
| Property / Sixth Author string | |||
| + | Jeong Dong Kee | ||
| Property / Sixth Author string: Jeong Dong Kee / rank | |||
| + | Normal rank | ||
Revision as of 13:55, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Chandimali Nisansala
0 references
Huynh Do Luong
0 references
Zhang Jiao Jiao
0 references
10-Sep
0 references
2018
0 references
Cancer Gene Therapy
0 references
26
0 references
MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells (English)
0 references
292-304
0 references
Lee Jae Cheol
0 references
Yu Dae-Yeul
0 references
Jeong Dong Kee
0 references
